Drug maker SynCore Biotechnology Co (杏國) is likely to swing into the black in 2020 after it launches its new drug for treating triple-negative breast cancer, Jih Sun Securities Investment Consulting Co (日盛投顧) said.
The company’s breast cancer drug SB05 (Endo-TAG 1), which it acquired from German-based MediGene AG last year, is currently under phase three clinical trials in Belgium and might enter phase three clinical trials in Australia soon, Jih Sun Securities analyst Chang Li-chun (張立群) said in a report issued on Friday.
SynCore purchased a 6.09 percent stake in the German company for NT$94 million (US$3.1 million) on May 27 last year.
Chang said the drug would likely hit the market in 2019 and start generating revenue for SynCore in the following year, according to the report.
He forecast sales of the drug would gradually pick up and reach its peak sales of US$512 million in 2024, with SynCore likely receiving 41 percent of the sales as royalties starting in 2020 at NT$61.5 billion.
Global sales for drugs for treating breast cancer are about US$11 billion a year, Chang said.
In addition, SynCore is developing SB04, a drug to treat dry age-related macular degeneration, and Jih Sun Securities estimated sales of the drug would be US$250 million a year in Asia starting 2021, when SynCore launches the drug.
Eyeing the potential sales of the two drugs, Jih Sun Securities rated the company’s shares at “buy.”
The stock is set to shift its listing to the GRETAI Securities Market from the Emerging Stock Market by the end of next month, through issuing 6.87 million new shares with prices tentatively set at between NT$80 and NT$100 per share, according to SynCore.
From January through last month, the company registered revenue of NT$3.13 million on sales of Veregen, a drug licensed from MediGene to treat genital warts caused by human papillomavirus. The company launched the drug in Taiwan in November last year.
In the first six months of this year, the company posted losses of NT$101 million, or NT$1.96 per share, compared with losses of NT$33.23 million, or NT$0.76 per share, the previous year due to higher expenses for research and development, according to the company’s filing to the Taiwan Stock Exchange.
SynCore plans to spend NT$1.05 billion from next year through 2018 to develop SB05 and spend another NT$700 million from this year through 2019 on SB04 research, Chang said.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”